Dr. Ruth O’Regan presents SABCS 2025 data showing how the Breast Cancer Index (BCI) identifies premenopausal patients with early-stage HR-positive, node-negative breast cancer at minimal risk of distant recurrence, helping guide less intensive endocrine therapy decisions.
